Eli Lilly's diabetes and weight-loss drug, Mounjaro, has received a "positive" response in India, with the company now focusing on meeting the significant demand in the world's most populous country. Lilly launched Mounjaro in India in March, ahead of competitor Novo Nordisk, tapping into a market grappling with increasing rates...